This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

David Siegel, MD, MPH; Stephen B. Hulley, MD, MPH
University of California San Francisco

JAMA. 1992;268(1):53.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—We agree with Drs Clarfield, Friedman, and Bergman that hypertension is an important risk factor in the elderly; in fact, some of our previous work is on this topic.¹ However, the present study focused on middle-aged men because the goal was to examine findings in the Multiple Risk Factor Intervention Trial (MRFIT), which found an association between diuretic therapy (especially hydrochlorothiazide) and an increased rate of sudden death in hypertensive men 35 to 57 years of age with electrocardiographic abnormalities.² In our study, we extended the age range to 35 to 70 years. It is of interest that the Systolic Hypertension in the Elderly Program study cited by Clarfield and colleagues restricted enrollment to individuals 60 years and above. There may be research questions [ill] most appropriate for particular age groups.

In general, we agree with the thrust of Dr Papademetriou's work, which indicates that hydrochlorothiazide . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?